Daniel Javitt
Gründer bei NeuroRx, Inc.
Vermögen: 4 Mio $ am 31.05.2024
Profil
Daniel C.
Javitt is associated with NeuroRx, Inc. as a Co-Chairman since 2015.
He is the founder of NeuroRx, Inc. which was founded in 2015.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.04.2024 | 987 291 ( 9,23% ) | 4 Mio $ | 31.05.2024 |
Aktive Positionen von Daniel Javitt
| Unternehmen | Position | Beginn |
|---|---|---|
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Gründer | 01.01.2015 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
NeuroRx, Inc.
NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Health Technology |
